These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 20157052)

  • 1. Accelerated development of pressure overload-induced cardiac hypertrophy and dysfunction in an RyR2-R176Q knockin mouse model.
    van Oort RJ; Respress JL; Li N; Reynolds C; De Almeida AC; Skapura DG; De Windt LJ; Wehrens XH
    Hypertension; 2010 Apr; 55(4):932-8. PubMed ID: 20157052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of RyR2 phosphorylation at S2814 during heart failure progression.
    Respress JL; van Oort RJ; Li N; Rolim N; Dixit SS; deAlmeida A; Voigt N; Lawrence WS; Skapura DG; Skårdal K; Wisløff U; Wieland T; Ai X; Pogwizd SM; Dobrev D; Wehrens XH
    Circ Res; 2012 May; 110(11):1474-83. PubMed ID: 22511749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical abnormalities in sarcoplasmic reticulum Ca(2+) release promote eccentric myocardial remodeling and pump failure death in response to pressure overload.
    Sedej S; Schmidt A; Denegri M; Walther S; Matovina M; Arnstein G; Gutschi EM; Windhager I; Ljubojević S; Negri S; Heinzel FR; Bisping E; Vos MA; Napolitano C; Priori SG; Kockskämper J; Pieske B
    J Am Coll Cardiol; 2014 Apr; 63(15):1569-79. PubMed ID: 24315909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology.
    Fischer TH; Herting J; Tirilomis T; Renner A; Neef S; Toischer K; Ellenberger D; Förster A; Schmitto JD; Gummert J; Schöndube FA; Hasenfuss G; Maier LS; Sossalla S
    Circulation; 2013 Aug; 128(9):970-81. PubMed ID: 23877259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
    Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
    Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
    Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ
    Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy.
    Zou Y; Liang Y; Gong H; Zhou N; Ma H; Guan A; Sun A; Wang P; Niu Y; Jiang H; Takano H; Toko H; Yao A; Takeshima H; Akazawa H; Shiojima I; Wang Y; Komuro I; Ge J
    Hypertension; 2011 Dec; 58(6):1099-110. PubMed ID: 21986507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIC-A Channel Maintains Store Calcium Handling by Interacting With Type 2 Ryanodine Receptor in Cardiac Muscle.
    Zhou X; Park KH; Yamazaki D; Lin PH; Nishi M; Ma Z; Qiu L; Murayama T; Zou X; Takeshima H; Zhou J; Ma J
    Circ Res; 2020 Feb; 126(4):417-435. PubMed ID: 31805819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure.
    van Oort RJ; McCauley MD; Dixit SS; Pereira L; Yang Y; Respress JL; Wang Q; De Almeida AC; Skapura DG; Anderson ME; Bers DM; Wehrens XH
    Circulation; 2010 Dec; 122(25):2669-79. PubMed ID: 21098440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho-kinase inhibition reverses impaired Ca
    Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
    Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q
    Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
    Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation.
    Campbell HM; Quick AP; Abu-Taha I; Chiang DY; Kramm CF; Word TA; Brandenburg S; Hulsurkar M; Alsina KM; Liu HB; Martin B; Uhlenkamp D; Moore OM; Lahiri SK; Corradini E; Kamler M; Heck AJR; Lehnart SE; Dobrev D; Wehrens XHT
    Circulation; 2020 Sep; 142(12):1159-1172. PubMed ID: 32683896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.
    Ling H; Zhang T; Pereira L; Means CK; Cheng H; Gu Y; Dalton ND; Peterson KL; Chen J; Bers D; Brown JH
    J Clin Invest; 2009 May; 119(5):1230-40. PubMed ID: 19381018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of β-adrenergic-stimulated phosphorylation of CaV1.2 channels on Ser1700 leads to heart failure.
    Yang L; Dai DF; Yuan C; Westenbroek RE; Yu H; West N; de la Iglesia HO; Catterall WA
    Proc Natl Acad Sci U S A; 2016 Dec; 113(49):E7976-E7985. PubMed ID: 27864509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac hypertrophy associated with impaired regulation of cardiac ryanodine receptor by calmodulin and S100A1.
    Yamaguchi N; Chakraborty A; Huang TQ; Xu L; Gomez AC; Pasek DA; Meissner G
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H86-94. PubMed ID: 23666671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Ca
    Ni M; Li Y; Wei J; Song Z; Wang H; Yao J; Chen YX; Belke D; Estillore JP; Wang R; Vallmitjana A; Benitez R; Hove-Madsen L; Feng W; Chen J; Roston TM; Sanatani S; Lehman A; Chen SRW
    Circ Res; 2023 Jul; 133(2):177-192. PubMed ID: 37325910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysferlin Enables Tubular Membrane Proliferation in Cardiac Hypertrophy.
    Paulke NJ; Fleischhacker C; Wegener JB; Riedemann GC; Cretu C; Mushtaq M; Zaremba N; Möbius W; Zühlke Y; Wedemeyer J; Liebmann L; Gorshkova AA; Kownatzki-Danger D; Wagner E; Kohl T; Wichmann C; Jahn O; Urlaub H; Toischer K; Hasenfuß G; Moser T; Preobraschenski J; Lenz C; Rog-Zielinska EA; Lehnart SE; Brandenburg S
    Circ Res; 2024 Aug; 135(5):554-574. PubMed ID: 39011635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.